BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 23689221)

  • 1. Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey.
    Steegmann JL; Sánchez Torres JM; Colomer R; Vaz Á; López J; Jalón I; Provencio M; González-Martín A; Pérez M
    Clin Transl Oncol; 2013 Jun; 15(6):477-83. PubMed ID: 23263906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY.
    Birgegård G; Gascón P; Ludwig H
    Eur J Haematol; 2006 Nov; 77(5):378-86. PubMed ID: 17044835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaemia in Hospitalized Cancer Patients: A Retrospective Study of Two Cohorts before and after the Guideline Update.
    Le Dû K; Septans AL; Dômont J; Dupuis O; Emmanuel E; Peribois A; Gaillard S; Allix-Béguec C
    Oncol Res Treat; 2024 May; ():1-8. PubMed ID: 38714181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical Clinical Consensus Guidelines for the Management of Cancer Associated Anemia in Low- and Middle-Income Countries.
    Parikh PM; Aggarwal S; Biswas G; Gulia S; Agarwala V; Basade M; Mohapatra PN; Vamshi KM; Warrier A; Prasad K; Roy P; Chandrakant MV; Malhotra H; Hingmire S; Paul D; Maniar V; Gupta A; Panda SS; Samar A; Rohatgi N; Dattatreya S; Krishnamurthy M; Thirumalairaj R
    South Asian J Cancer; 2023 Apr; 12(2):93-99. PubMed ID: 37969669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis.
    Adams A; Scheckel B; Habsaoui A; Haque M; Kuhr K; Monsef I; Bohlius J; Skoetz N
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD012633. PubMed ID: 35724934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies.
    Lebrun F; Klastersky J; Levacq D; Wissam Y; Paesmans M
    Support Care Cancer; 2017 Jul; 25(7):2313-2319. PubMed ID: 28386789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there any role of intravenous iron for the treatment of anemia in cancer?
    Gemici C; Yetmen O; Yaprak G; Ozden S; Tepetam H; Ozyurt H; Mayadagli A
    BMC Cancer; 2016 Aug; 16(1):661. PubMed ID: 27542823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of anemia and iron deficiency in a cancer center in France.
    Laï-Tiong F; Brami C; Dubroeucq O; Scotté F; Curé H; Jovenin N
    Support Care Cancer; 2016 Mar; 24(3):1091-6. PubMed ID: 26253586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia.
    Ludwig H; Aapro M; Bokemeyer C; Glaspy J; Hedenus M; Littlewood TJ; Österborg A; Rzychon B; Mitchell D; Beguin Y
    Support Care Cancer; 2014 Aug; 22(8):2197-206. PubMed ID: 24659244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.
    de Mello RA; Gerós S; Alves MP; Moreira F; Avezedo I; Dinis J
    PLoS One; 2014; 9(2):e86697. PubMed ID: 24516537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.
    Ludwig H; Aapro M; Bokemeyer C; Macdonald K; Soubeyran P; Turner M; Albrecht T; Abraham I
    Eur J Cancer; 2009 Jun; 45(9):1603-15. PubMed ID: 19278851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-related anemia: pathogenesis, prevalence and treatment.
    Birgegård G; Aapro MS; Bokemeyer C; Dicato M; Drings P; Hornedo J; Krzakowski M; Ludwig H; Pecorelli S; Schmoll H; Schneider M; Schrijvers D; Shasha D; Van Belle S
    Oncology; 2005; 68 Suppl 1():3-11. PubMed ID: 15855811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cancer-associated anaemia: results from a two-day cross-sectional survey in Germany.
    Link H; Schmitz S
    Onkologie; 2013; 36(5):266-72. PubMed ID: 23689221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.
    Ludwig H; Van Belle S; Barrett-Lee P; Birgegård G; Bokemeyer C; Gascón P; Kosmidis P; Krzakowski M; Nortier J; Olmi P; Schneider M; Schrijvers D
    Eur J Cancer; 2004 Oct; 40(15):2293-306. PubMed ID: 15454256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?
    Kosmidis P; Krzakowski M;
    Lung Cancer; 2005 Dec; 50(3):401-12. PubMed ID: 16191450
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.